Prometheus Biosciences (RXDX) reported promising results for one of its drugs in two inflammatory disease studies on Wednesday, and RXDX stock catapulted by triple digits. X The company studied its dr...
Prometheus Biosciences (RXDX) reported promising results for one of its drugs in two inflammatory disease studies on Wednesday, and RXDX stock catapulted by triple digits. X The company studied its dr...